Japan· JP-2590005F1022
オキシブチニン塩酸塩
A medicinal product containing オキシブチニン塩酸塩, registered in Japan by チェプラファーム, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- オキシブチニン塩酸塩
- Manufacturer
- チェプラファーム
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
オキシブチニン塩酸塩 in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesoxybutyninZydus Pharmaceuticals USA Inc.
- United KingdomCystrin 3mg tabletsSanofi
- FinlandContrinFerring Ab
- NetherlandsDridase, strooppharmaand GmbH
- PolandDitropanInPharm Sp. z o.o.
- SwedenDitropan 5 mg TablettCheplapharm Arzneimittel GmbH
- CzechiaKENTERATeva B.V., Haarlem
- GermanyDridaseCheplapharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Detrusan, Ditropan
- Belgium · Oxybutynine Eg, Velariq
- Bulgaria · Дриптан
- Czechia · Tarraconiq, Uroxal
- Germany · Dridase, Oxybutynin Aaa-Pharma
- Denmark · Oxybutynin Macure, Oxybutynin Unimedic
- Estonia · Driptane
- Spain · Ditropan, Dresplan
- Finland · Oxybutynin Macure, Oxybutynin Unimedic
- France · Ditropan, Oxybutynine Accord
- United Kingdom (Northern Ireland) · Ditropan, Oxybutynin Hydrochloride
- Greece · Ditropan
- Hungary · Ditropan, Uroxal
- Ireland · Oxybutynin Hydrochloride Accord Healthcare Ireland, Oxybutynin Hydrochloride Syri Pharma
- Iceland · Kentera
- Italy · Ditropan, Ossibutinina Cloridrato Mylan Generics
- Liechtenstein · Kentera
- Lithuania · Driptane
- Luxembourg · Oxybutynine Eg, Velariq
- Latvia · Driptane
- Netherlands · Dridase, Oxybutinin Hydrochloride Aurobindo
- Norway · Kentera, Oxybutynin Macure
- Poland · Ditropan, Driptane
- Portugal · Ditropan, Velariq
- Romania · Driptane
- Sweden · Ditropan, Oxybutynin Accord
- Slovakia · Uroxal, Velariq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eefb523e-8520-46bb-a78d-56b7106a44a0 GET /v1/drugs/eefb523e-8520-46bb-a78d-56b7106a44a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2590005F1022",
"category": "内用薬",
"price_yen": 9.4,
"generic_name": "オキシブチニン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2590",
"transitional_expiry": null
}See everything about オキシブチニン塩酸塩.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.